CBC's Quirks & Quarks features AmacaThera Co-Founder Dr. Molly Shoichet

   Media Coverage

ICYMI: Thanks to CBC’s Quirks and Quarks for re-running this November 2020 interview with our co-founder, Dr. Molly Shoichet.

She spoke with Bob McDonald about winning the Gerhard Herzberg Canada Gold Medal and her research in hydrogel materials. AMT-143, our lead product, is grounded in this research and is currently approved for a Phase I clinical trial.

Listen to the interview or read the news story.

More Recent News

AmacaThera CEO Mike Cooke accepted to adMare BioInnovations 2021-22 Executive Institute

   Press Release

adMare BioInnovations is pleased to announce the nine women and nine men from diverse backgrounds and representing a wide range of life science businesses across the country, selected to join this year’s adMare Academy Executive Institute.Read more

Top20 Amaca Thera FB

AmacaThera named CIX Top 20 Early company

   Press Release

Amacathera Inc. has been named a Canadian Innovation Exchange (CIX)’s Top 20 Early company for 2021.Read more

Out of the lab molly

Out of the lab, into the marketplace

   Media Coverage

Globe and Mail features AmacaThera’s Series A financingRead more